Exodus Point Capital Management, LP Exact Sciences Corp Transaction History

Exodus Point Capital Management, LP

  • $9.1 Billion
  • Q3 2025

A detailed history of Exodus Point Capital Management, LP transactions in Exact Sciences Corp stock. As of the latest transaction made, Exodus Point Capital Management, LP holds 75,306 shares of EXAS stock, worth $5.05 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares
75,306
Previous 65,701 14.62%
Holding current value
$5.05 Million
Previous $3.49 Million 17.99%
% of portfolio
0.05%
Previous 0.03%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 14, 2025
BUY
$40.91 - $56.0 $392,940 - $537,880
9,605 Added 14.62%
75,306 $4.12 Million
Q2 2025

Aug 13, 2025
BUY
$40.31 - $58.08 $2.65 Million - $3.82 Million
65,701 New
65,701 $3.49 Million
Q4 2024

Feb 12, 2025
BUY
$49.33 - $71.97 $6.67 Million - $9.73 Million
135,245 Added 223.38%
195,791 $11 Million
Q3 2024

Nov 12, 2024
BUY
$42.43 - $70.83 $2.57 Million - $4.29 Million
60,546 New
60,546 $4.12 Million
Q1 2024

May 14, 2024
BUY
$56.27 - $73.77 $4.56 Million - $5.98 Million
81,058 Added 66.27%
203,378 $14 Million
Q3 2023

Nov 09, 2023
BUY
$65.94 - $99.04 $6.91 Million - $10.4 Million
104,842 Added 599.85%
122,320 $8.35 Million
Q2 2023

Aug 10, 2023
BUY
$62.68 - $95.05 $245,454 - $372,215
3,916 Added 28.87%
17,478 $1.64 Million
Q1 2023

May 11, 2023
SELL
$47.19 - $70.77 $2.11 Million - $3.17 Million
-44,730 Reduced 76.73%
13,562 $920,000
Q4 2022

Feb 13, 2023
SELL
$30.35 - $53.15 $382,410 - $669,690
-12,600 Reduced 17.77%
58,292 $2.89 Million
Q3 2022

Nov 10, 2022
BUY
$31.97 - $49.37 $2.27 Million - $3.5 Million
70,892 New
70,892 $2.3 Million
Q1 2022

May 13, 2022
SELL
$57.56 - $82.54 $727,500 - $1.04 Million
-12,639 Closed
0 $0
Q4 2021

Feb 11, 2022
BUY
$72.5 - $100.68 $916,327 - $1.27 Million
12,639 New
12,639 $984,000
Q1 2021

May 17, 2021
SELL
$116.57 - $155.01 $468,378 - $622,830
-4,018 Closed
0 $0
Q4 2020

Feb 16, 2021
BUY
$99.61 - $142.12 $292,156 - $416,837
2,933 Added 270.32%
4,018 $532,000
Q3 2020

Nov 16, 2020
SELL
$72.92 - $102.01 $1.98 Million - $2.77 Million
-27,143 Reduced 96.16%
1,085 $111,000
Q2 2020

Aug 14, 2020
BUY
$55.75 - $92.75 $1.57 Million - $2.62 Million
28,228 New
28,228 $2.45 Million
Q1 2020

May 15, 2020
SELL
$37.9 - $104.44 $90,391 - $249,089
-2,385 Closed
0 $0
Q4 2019

Feb 14, 2020
SELL
$77.66 - $99.74 $39,994 - $51,366
-515 Reduced 17.76%
2,385 $221,000
Q3 2019

Nov 14, 2019
BUY
$90.37 - $122.49 $262,073 - $355,221
2,900 New
2,900 $262,000
Q2 2019

Aug 14, 2019
SELL
$89.51 - $118.04 $7.06 Million - $9.3 Million
-78,819 Closed
0 $0
Q1 2019

May 15, 2019
BUY
$61.98 - $96.5 $4.89 Million - $7.61 Million
78,819 New
78,819 $6.83 Million

Others Institutions Holding EXAS

# of Institutions
670
Shares Held
164M
Call Options Held
2.2M
Put Options Held
1.69M
View Full List

About EXACT SCIENCES CORP

EXAS Quotes by TradingView
  • Ticker EXAS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 176,960,000
  • Market Cap $11.9B
  • Description
  • Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...
More about EXAS
Track This Portfolio

Track Exodus Point Capital Management, LP Portfolio

Follow Exodus Point Capital Management, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Exodus Point Capital Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Exodus Point Capital Management, LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email